Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-27 @ 11:19 PM
Study NCT ID:
NCT01950260
Status:
COMPLETED
Last Update Posted:
2019-10-29
First Post:
2013-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Early Levothyroxine Post Radioactive Iodine
Sponsor:
Mayo Clinic
Organization:
Study Overview
Official Title:
Prevention of Overt Hypothyroidism Following Radioactive Iodine Therapy for Graves' Disease
Status:
COMPLETED
Status Verified Date:
2019-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will try to answer the question of whether early treatment with levothyroxine at 4 weeks after radioactive iodine for Graves'disease will prevent overt hypothyroidism (low thyroid hormone levels).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: